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Summary
Induced pluripotent stem (iPS) cells have been derived from
fibroblast, stomach, and liver cultures at extremely low
frequencies by ectopic expression of the transcription fac-
tors Oct4, Sox2, c-myc, and Klf4, a process coined direct
or in vitro reprogramming [1–8]. iPS cells are molecularly
and functionally highly similar to embryonic stem cells
(ESCs), including their ability to contribute to all tissues as
well as the germline in mice. The heterogeneity of the start-
ing cell populations and the low efficiency of reprogramming
suggested that a rare cell type, such as an adult stem cell,
might be the cell of origin for iPS cells and that differentiated
cells are refractory to reprogramming. Here, we used induc-
ible lentiviruses [9] to express Oct4, Sox2, c-myc, and Klf4
in pancreatic b cells to assess whether a defined terminally
differentiated cell type remains amenable to reprogramming.
Genetically marked b cells gave rise to iPS cells that ex-
pressed pluripotency markers, formed teratomas, and con-
tributed to cell types of all germ layers in chimeric animals.
Our results provide genetic proof that terminally differenti-
ated cells can be reprogrammed into pluripotent cells, sug-
gesting that in vitro reprogramming is not restricted to cer-
tain cell types or differentiation stages.
Results and Discussion
Pancreatic b cells are mature, fully differentiated cells, whose
defining characteristic is the expression of insulin. In vivo line-
age-tracing studies have demonstrated that in healthy adult
mice, the b cell population is maintained by self-duplication,
not an adult stem cell [10]. Upon injury, insulin-producing
b cells are also produced from facultative endocrine progeni-
tors [11]. Importantly, these progenitors do not express insulin.
Moreover, insulin-expressing b cells do not contribute to any
other cell type in vivo [10]. Because of their easily defined iden-
tity and stable cell fate, pancreatic b cells are an ideal cell type
with which to test whether iPS cells can be derived from a
terminally differentiated cell type.
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4These authors contributed equally to this workWe first tested whether b cells can be cultured under iPS cell
culture conditions. To this end, we explanted pancreatic islets
from 3- to 4-month-old mice that expressed GFP under the
control of thePdx1 promoter [12]. Pdx1 expression in the post-
natal pancreas is confined tobcells, in which it regulates insulin
expression [13]. As shown in Figure 1, most islet cells were
GFP+ and maintained GFP expression in culture for at least 12
days. Rare GFP2 fibroblast-like cells appeared afterw1 week
(Figures 1D and 1E). Most of these cells are probably derived
from the pancreatic mesenchyme [12], whereas rare cells
may also originate from b cells that have dedifferentiated in cul-
ture, as previously observed [14]. On the basis of the expansion
of islets in culture, we estimated thatbcells divided once before
arresting. Incubation with a lentivirus constitutively expressing
tdTomato showed that roughly 50% of GFP+ islet cells (148 of
279 counted cells) became infected, compared with 80% of
adult fibroblasts (209 of 261 cells), indicating that cultured islet
cells can be transduced with lentivirus, albeit at a lower effi-
ciency than fibroblasts (Figures 1F and 1G and data not shown).
To genetically mark b cells in the adult, we crossed RIP-Cre
mice, in which the Cre gene is controlled by the b cell-specific
rat insulin promoter [15], with ROSA26-lacZ reporter mice
(Figure 2A). Immunostaining of pancreas sections showed that
lacZ expression was restricted to insulin+ cells contained within
b islets, thus confirming the specificity of the transgene and ex-
cluding the possibility that non-bcells had been labeled (Figures
2B and 2C) [10]. On the basis of this observation, we conclude
that most, if not all, cells with an active rat insulin promoter in
the adult pancreas correspond to differentiated b cells.
Pancreatic islets from RIP-Cre/lacZ mice were isolated,
explanted in culture for 2 days, and infected with doxycy-
cline-inducible lentiviruses expressing Oct4, Sox2, c-myc,
and Klf4 as well as a lentivirus constitutively expressing the re-
verse tetracycline-dependent transactivator (rtTA). Eighteen
to twenty-four days after adding doxycycline to the cultures,
colonies emerged that were visually different from pancreatic
islets and resembled iPS colonies derived from fibroblasts
(Figure 3B). The delayed kinetics with which iPS colonies ap-
peared from pancreatic cultures compared with fibroblast cul-
tures [9] may reflect the slow replication rate of islet cells. A to-
tal of 24 colonies were picked at day 24, andw80% (19/24) of
the colonies could be expanded in the absence of doxycycline,
demonstrating independence of viral gene expression and ac-
tivation of the endogenous pluripotency program, as has been
seen previously [9, 16].
To verify the cellular origin of iPS cells, we stained the 19 ex-
panded clones with the b-galactosidase substrate 5-bromo-
4-chloro-3-indolyl-b-D-galactopyranoside (Xgal). Four of the
clones (21%) stained homogenously positive with Xgal, dem-
onstrating that they were derived from insulin-expressing b
cells (Figure 2C), whereas all other clones were entirely Xgal2.
This number is significantly lower than the labeling efficiency
of b cells with the RIP-Cre transgene (>80%), suggesting that
Xgal2 cells within explanted islets may be more easily reprog-
rammed or more efficiently infected by lentiviruses compared
with b cells. Alternatively, the ROSA26 locus may have been si-
lenced in some of the Xgal2 iPS cell clones. iPS cells derived
from b cells will be referred to as b iPSs.
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891Figure 1. Culture and Viral Infection of Pancreatic Islets
(A–E) Bright-field (upper panel) and fluorescence (lower panel) images of a representative pancreatic islet isolated from Pdx1-GFP mice and imaged after the
indicated culture periods. Note that most cells in the islet remain GFP+ and that islet cells stop expanding after one to two cell divisions. Rare GFP2 fibro-
blast-like cells present in the cultures are indicated by arrows in (D) and (E).
(F and G) Images of tail-tip fibroblasts (F) and islet cells from Pdx1-GFP mice (G) infected with a lentivirus constitutively expressing the red-fluorescent pro-
tein tdTomato.We estimated the reprogramming efficiency to range
between 0.1% and 0.2% (for calculation, see Experimental
Procedures), which is similar to that seen in fibroblast cultures
with the same lentiviral system [9]. To rule out the possibility
that the RIP-Cre transgene becomes activated during the
reprogramming process, we generated iPS cells from tail fibro-
blasts of RIP-Cre/lacZ mice in which the insulin promoter is
silenced. Out of more than 50 iPS clones analyzed, none
stained positive for Xgal, thus confirming the tightness of the
RIP-Cre/lacZ system (data not shown).All four b iPS clones expressed the pluripotency markers
SSEA1, Nanog, Sox2, and Oct4 at the protein level (Figures
3D–3F and data not shown), indicating faithful molecular re-
programming. Real-time quantitative PCR analysis showed
that b iPSs expressed endogenous c-myc, Klf4, Oct4, and
Sox2 at levels comparable to ESCs, whereas viral gene prod-
ucts were essentially undetectable (Figure S1 available online).
To test the differentiation potential of b iPS cells, we injected
the four cell lines into the flanks of SCID mice. All b iPS lines
formed teratomas, which on histological examination showedFigure 2. Characterization of RIP-Cre/lacZ Pan-
creas
(A) Scheme illustrating b cell-specific activation
of lacZ expression in RIP-Cre/lacZ mice.
(B) Frozen pancreas sections from a RIP-Cre/
lacZ mouse after Xgal staining shows islet spe-
cific labeling.
(C) Immunofluorescence staining of a RIP-Cre/
lacZ islet section with antibodies against insulin
(red) and b-galactosidase (green) demonstrates
exclusive expression of b-galactosidase in insu-
lin-positive b cells. The position of a rare b cell
not expressing b-galactosidase is highlighted
by white arrows.
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including glandular structures, muscle fibers, keratinized epi-
thelia, and cartilage (Figures 4A–4E). Next, we injected three
of the four iPS clones into blastocysts to assess their potential
to contribute to normal development. All clones gave rise to
E14.5 fetal chimeras and neonatal animals that were highly
chimeric on the basis of whole-mount staining for lacZ activity,
and cross sections of individual organs showed widespread
tissue contribution (Figures 4F–4J and data not shown). One
surviving chimera showed obvious coat-color chimerism but
was cannibalized by its littermates at three weeks of age
(data not shown). Together, these analyses demonstrate that
the b iPS cells were reprogrammed to a pluripotent state.
Our findings allow three major conclusions. First, using
genetic-lineage analysis, we demonstrate that cells from a de-
fined cellular lineage can be reprogrammed into iPS cells that
broadly contribute to tissues in chimeras. Second, our data
show that reprogramming is not only confined to mesodermal
derivatives, which have been used previously, but is also pos-
sible with an endodermally derived cell type. This is in agree-
ment with a recent report showing reprogramming of stomach
and liver cells into iPS cells [1]. Third, terminal differentiation,
at least in the b cell lineage, does not restrict a cell’s potential
to be reprogrammed by the four reprogramming factors
c-myc, Klf4, Oct4, and Sox2. In a previous report, iPS cells
have been derived from genetically marked, albumin-express-
ing liver cells [1]. Because albumin is also expressed in hepatic
Figure 3. Generation of b iPS Cells
(A) Experimental outline.
(B) Bright-field images showing two typical iPS
colonies obtained after lentiviral infection of islet
cultures.
(C) Xgal staining of iPS lines derived from islets
shows that 4 of the 12 depicted lines express b-
galactosidase from the ROSA26 promoter.
(D and E) Bright-field and fluorescent images of b
iPS cells stained for the pluripotency markers
Nanog (D) and Sox2 (E). Nuclei were counter-
stained with DAPI.
(F) FACS histograms of three b iPS cell lines and
an ESC line stained for SSEA-1 (colored lines) or
with an isotype control (gray line).
progenitor and stem cells [17–19], this
experiment did not unequiovocally dem-
onstrate the reprogramming of differen-
tiated cells.
Our data indicate that the consistently
low efficiency of iPS cell derivation from
somatic cells is unlikely to reflect the re-
programming of rare stem or progenitor
cells present in the starting cell popula-
tion, suggesting that reprogramming is
a universal process that is not restricted
to certain cell types or differentiation
stages. This does not exclude the possi-
bility, however, that adult stem and
progenitor cells are more amenable to
in vitro reprogramming than differenti-
ated cells. In agreement with this, pro
B cells have been reported to be more
easily reprogrammed into iPS cells
than mature B cells, which required
additional genetic manipulation of the B-cell-specific tran-
scription factor Pax5 [20]. We believe that stochastic epige-
netic-remodeling events are necessary for successful reprog-
ramming, which results in the low overall reprogramming
efficiencies. The requirement for such remodeling events or
the frequency at which they occur might be cell type specific.
Thus, it is conceivable that the genetic or pharmacologic
manipulation of epigenetic modifiers may significantly increase
reprogramming efficiencies in different cellular contexts.
Experimental Procedures
Mice
Derivation and handling of Pdx1-GFP, RIP-Cre, and R26R-lacZ mice were
described previously. We crossed RIP-Cre mice with R26R-lacZ mice to ob-
tain RIP-Cre/lacZ animals. Genotyping was done by PCR with the following
oligonucleotides for RIP-Cre: 50-TAGCACCAGGCAAGTGTTTG-30 and 50-A
TGTTTAGCTGGCCCAAATG-30. Genotyping for ROSA26 was done as
described [21].
Isolation of Pancreatic Islets
The pancreas was perfused through the bile duct with digestion solution
(low-glucose DMEM [GIBCO] with 10 mM HEPES [GIBCO], 0.25 mg/ml
Liberase RI [Roche], and 0.1 mg/ml ovalbumin trypsin inhibitor [Roche]),
dissected, and incubated at 37C for 20 min. Cold washing solution (low-
glucose DMEM with 10 mM HEPES, 10% FBS [Hyclone], and 0.1 mg/ml
OTI) was added, and islets were centrifuged, washed twice, and filtered
through a 500 mm diameter wire mesh. Islets were centrifuged, washed
twice in washing solution, resuspended in Histopaque 1077 (Sigma), and
vortexed. The islet suspension was carefully overlaid with washing solution
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893(without serum) and centrifuged for 20 min at 10C, separating islets from
exocrine tissue. The islet layer was collected at the interface, pelleted,
and washed twice. Finally, pure islets were handpicked under a dissecting
scope, pelleted, washed, and cultured in ES medium on laminin coated
plates.
Calculation of b Cell Reprogramming Efficiency
The number of islets that attached 1 day after seeding was determined to
be w500 islets per 35 mm plate. On the basis of an average number of
100 b cells per islet (K.B. and D. Melton, unpublished data), and a labeling
efficiency of 80% in RIP-Cre mice [15], we calculated the total number of
Xgal+ cells present in the cultures to be w40,000. Because w50% of cells
were infected by individual lentiviruses (Figure 1), we calculated the number
of Xgal+ b cells infected by all four viruses to be 2500 (40,0003 0.54). Out of
2500 cells, we obtained four Xgal+ iPS clones at an efficiency of 0.16%.
Teratoma Formation
iPS cells were harvested by trypsinization, preplated onto untreated culture
plates for removal of feeders as well as differentiating cells, and injected into
the flanks of NOD/SCID mice, withw5 million cells per injection. Mice were
sacrificed 3 weeks later, and teratomas were isolated and processed for his-
tological analysis.
Production of Chimeric Mice
Female BDF1 mice were superovulated with PMS and hCG and mated to
BDF1 stud males. Zygotes were isolated from females with a vaginal plug
24 hr after hCG injection. After 3 days of in vitro culture in KSOM media, blas-
tocysts were identified, injected with iPS cells, and transferred into pseudo-
pregnant recipient females. Pups were delivered by Cesarean section at day
19.5 and nurtured by foster mothers.
Xgal Stainings
Cultured cells were fixed with 0.2% glutaraldehyde for 15 min and incubated
in X-gal staining solution (0.1 M phosphate buffer with 2 mM MgCl2, 5 mM
potassium ferrocyanide, and 5 mM potassium ferricyanide containing 1
mg/ml X-gal [5-bromo-4-chloro-3-indolyl-b-D-galactosidase]) for 12–16 hr
at 37C. Teratomas and newborn mice were fixed overnight in 1.5% parafor-
maldehyde (PFA) and washed with PBS before incubation in X-gal staining
solution. For analysis of tissue chimerism, PFA-fixed newborn mice were
equilibrated in 30% sucrose solution and frozen in OCT compound. Ten mi-
crometer cryosections were prepared and incubated in X-gal staining solu-
tion overnight.
Immunofluorescence
iPS cells were cultured on pretreated coverslips, fixed with 4% PFA, and
permeabilized with 0.5% Triton X-100. The cells were then stained with
primary antibodies against mOct4 (Santa Cruz, sc-8628), mSox2 (Chemi-
con, AB5603), and mNanog (Abcam, ab21603); this was followed by staining
with the respective secondary antibodies conjugated to Alexa Fluor 546 (In-
vitrogen). Nuclei were counterstained with DAPI (Invitrogen). Cells were im-
aged with a Leica DMI4000B inverted fluorescence microscope equipped
with a Leica DFC350FX camera. Images were processed and analyzed
with Adobe Photoshop software.
Flow Cytometry
Cells were harvested and incubated with either an antibody against SSEA-1
(MC-480, Developmental Hybridoma Bank) or an IgM isotype control, sub-
sequently incubated with APC-conjugated mouse anti-mouse IgM antibody
(II/41, eBiosciences), and analyzed on LSR2 (BD Biosciences). Dead cells
were excluded by staining with DAPI. Data were analyzed with FlowJo soft-
ware (Tree Star).
Viral Production and Cell Transduction
The generation and structure of tet-inducible lentiviruses expressing c-myc,
Klf4, Sox2, and Oct4 has been described in detail elsewhere [9]. In brief,
a tet-inducible lentivirus termed LV-tetO was generated by replacement of
the ubiquitin promoter elements from the FUDGW vector [22] with tetO
sequences. cDNAs for c-MYC (T58A mutant), Klf4, Oct4, and Sox2 were iso-
lated from pMIG or pMX vectors and cloned into LV-tetO. The lentivirus con-
stitutively expressing tdTomato was a kind gift of Dr. Niels Geijsen, MGH. To
produce infectious viral particles, we transfected 293T cells cultured on 10
cm dishes with the LV-tetO vectors (11 mg) together with the packaging plas-
mids VSV-G (5.5 mg) and D8.9 (8.25 mg) using Fugene (ROCHE) transfection
reagent. Viral supernatants were harvested on 3 consecutive days starting
24 hr after transfection, yielding a total ofw30 ml of supernatant per virus.
Viral supernatant was concentrated w100-fold by ultracentrifugation at
20,000 rpm for 1.5 hr at 4C and resuspension in 300 ml PBS. Viral concen-
trates were stored at280C. Infections were carried out in 1 ml ES medium
containing 5 mg/ml polybrene with 5–10 ml of each viral concentrate per
35 mm plate. Fibroblasts were infected at passages 1 or 2 at a density of
w200,000 cells/plate. Primary islets cells were infected 2 days after seeding
them at a density ofw500 islets/plate. The medium was replaced 24 hr after
infection and supplemented with 1 mg/ml doxycycline another 24–48 hr later.
Irradiated feeders cells were added to the pancreatic culturesw10 hr after
viral induction.
RNA Isolation and qPCR
RNA was isolated from cells with the TriPure reagent (Roche), and this was
followed by RNA clean up with the RNeasy Minikit (QIAGEN). cDNA was pro-
duced with the First Strand cDNA Synthesis Kit (Roche). Real-time quantita-
tive PCR reactions were set up in triplicates with the Brilliant II SYBR Green
Figure 4. Developmental Potential of b iPS Cells
(A and B) Teratomas derived from b iPS (top im-
age) as well as from fibroblast-derived iPS cells
without a lacZ transgene (bottom image) were
used for whole-mount Xgal staining. The light-
blue staining seen in the control teratoma is due
to weak background b-galactosidase activity.
(C–E) Histological sections of teratomas derived
from b iPS cells subjected to H&E staining (with-
out Xgal staining) show muscle and glandular
cells (C) and keratinized epithelium (D) as well
as cartilagous tissue.
(F) Images of newborn wild-type (left) and chime-
ric mice derived after blastocyst injection of
b iPS. The tail of the chimeric mouse was used
for establishing fibroblast cultures.
(G–J) Images of Xgal-stained sections from a b
iPS-derived newborn chimera show both Xgal+
(iPS-derived, black arrowheads) and Xgal2 (blas-
tocyst-derived, white arrowheads) cells in the
vasculature (G), the bronchiolar epithelium of
the lung (H), the cartilage of the rib (I), and neuro-
nal tissue in the brain (J). Insets (red frames) show
close-ups of chimeric areas.
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894QPCR Master Mix (Stratagene) and run on an Mx3000P QPCR System (Stra-
tagene). Primer sequences are listed in Table S1.
Supplemental Data
One figure and one table are available at http://www.current-biology.com/
cgi/content/full/18/12/890/DC1/.
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